Petros Pharmaceuticals, Inc.·4

Apr 12, 6:00 PM ET

Bradley Greg 4

4 · Petros Pharmaceuticals, Inc. · Filed Apr 12, 2023

Insider Transaction Report

Form 4
Period: 2023-04-10
Bradley Greg
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-04-10+39,00039,000 total
    Exercise: $0.99Exp: 2033-04-10Common Stock (39,000 underlying)
Footnotes (1)
  • [F1]The stock options will vest on the one-year anniversary of the date of grant, provided that the Reporting Person has continued to provide services to Petros Pharmaceuticals, Inc. (the "Company") through the vesting date.

Documents

1 file
  • 4
    tm2312600-2_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT